Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients

Muscle & Nerve
C E JacksonMuscle Study Group

Abstract

Twenty ALS patients with sialorrhea refractory to medical therapy were enrolled in this double-blind, randomized study to receive either 2,500 U of botulinum toxin type B (BTxb) or placebo into the bilateral parotid and submandibular glands using electromyographic guidance. Patients who received BTxb reported a global impression of improvement of 82% at 2 weeks compared to 38% of those who received placebo (P < 0.05). This significant effect was sustained at 4 weeks. At 12 weeks, 50% of patients who received BTxb continued to report improvement compared to 14% of those who received placebo. There were no significant adverse events, including dysphagia, in the BTxb group, and there was no significant increase in the rate of decline of vital capacity.

References

Apr 25, 1992·British Dental Journal·W M Edgar
Jan 9, 1999·Journal of Child Neurology·E S RoachH Northrup
Nov 30, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K P BhatiaP Brown
Jan 15, 2000·Neurology·P K PalJ K Tsui
Jun 23, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·R GiessK V Toyka
Mar 16, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·M G WinterhollerS Kat
May 10, 2001·Parkinsonism & Related Disorders·A Friedman, A Potulska
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·B R BrooksUNKNOWN World Federation of Neurology Research Group on Motor Neuron Diseases
Jun 24, 2004·International Ophthalmology Clinics·Manoj M Thakker, Peter A D Rubin

❮ Previous
Next ❯

Citations

Apr 20, 2010·Der Nervenarzt·P KraftK V Toyka
Oct 14, 2009·Psychopharmacology·Susanne SteinlechnerJohann Hagenah
Jun 23, 2010·Current Neurology and Neuroscience Reports·Virgilio Gerald H Evidente, Charles H Adler
Mar 19, 2011·Journal of Palliative Medicine·Nathalie GuyPierre Clavelou
Jun 6, 2009·Journal of Clinical Neuromuscular Disease·Zachary Simmons
Apr 11, 2012·Current Opinion in Otolaryngology & Head and Neck Surgery·Nina SquiresJohn Rowson
Jul 17, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D ReddihoughUNKNOWN Cereral Palsy Institute
Sep 15, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies· Markus Weber
Sep 24, 2011·Journal of Toxicology·Domenico Intiso
Jul 26, 2011·Neurology International·Aline Furtado BastosVictor Hugo Bastos
Apr 15, 2014·International Journal of Pediatric Otorhinolaryngology·Sam J Daniel, Isabel Cardona
May 11, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Johnathan Cooper-KnockPamela Shaw
Aug 30, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Morten Gersel StokholmOle Jakob Vilholm
Sep 17, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Alexander J McGeachanChristopher J McDermott
May 8, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Esther V HobsonChristopher J McDermott
Jan 26, 2016·Acta Neurologica Scandinavica·J G WeikampJ G Kalf
May 18, 2010·Revue neurologique·P-F PradatUNKNOWN coordination des centres de prise en charge des patients atteints de SLA
Dec 15, 2015·Journal of Palliative Medicine·Kristin ScottAlva Roche-Green
Oct 2, 2014·Acta Neurologica Scandinavica·E MøllerM Bakke
Oct 31, 2015·Neurologic Clinics·Jeffrey M StatlandHiroshi Mitsumoto
Mar 19, 2011·Developmental Medicine and Child Neurology·Mario BascianiDomenico Intiso
Apr 2, 2016·Neurodegenerative Disease Management·Stephen C Bourke, John Steer
Jul 16, 2015·Journal of Neurology·Maria del Mar AmadorPierre-François Pradat
Sep 28, 2015·NeuroRehabilitation·Sabrina PaganoniGregory T Carter
Jan 13, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jeffrey Rosenfeld, Michael J Strong
Nov 28, 2012·Toxicon : Official Journal of the International Society on Toxinology·Markus NaumannDaniel Truong
Jul 6, 2011·Journal of the Neurological Sciences·Edward J KasarskisWilliam H St Clair
Jul 1, 2016·Rinshō shinkeigaku = Clinical neurology·Chiharu MatsudaMasanobu Kinoshita
Aug 16, 2016·Nature Reviews. Neurology·Esther V Hobson, Christopher J McDermott
Sep 1, 2016·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Alexander J McGeachanChristopher J McDermott
Dec 21, 2016·Journal of Palliative Medicine·April Zehm, Mihir Kamdar
Nov 1, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Rishi VashishtaM Boyd Gillespie
Sep 2, 2009·Arquivos de neuro-psiquiatria·Acary Souza Bulle Oliveira, Roberto Dias Batista Pereira
May 18, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·David OliverChristopher McDermott
Jun 1, 2017·Muscle & Nerve·Katharine NicholsonNazem Atassi
Oct 3, 2017·Continuum : Lifelong Learning in Neurology·Stephen A Goutman
Jul 7, 2017·Muscle & Nerve·Stephen A Goutman, Zachary Simmons
Dec 8, 2010·International Journal of Palliative Nursing·Pauline Dand, Mohamed Sakel
Jul 19, 2011·American Journal of Physical Medicine & Rehabilitation·Uwe KernTanja Schlereth
Jul 9, 2010·Current Opinion in Neurology·Richard S Bedlack
Apr 23, 2019·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Hiroshi MitsumotoBjÖrn Oskarsson
Sep 6, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Robert G Miller, Stanley H Appel
Oct 6, 2017·Nature Reviews. Disease Primers·Orla HardimanLeonard H van den Berg
May 13, 2011·The Cochrane Database of Systematic Reviews·Carolyn A YoungNicky Pih

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.